SCHEMBL4602744

SCHEMBL4602744

CC(C)COC([C]=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.40
CYP2D6 P10635 2/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.38
TAAR1 Q96RJ0 3/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MC4R P32245 1/20 0.34
HPGD P15428 1/20 0.34
CA12 O43570 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
GPR88 Q9GZN0 1/20 0.34
CYP1A2 P05177 1/20 0.33
PKM P14618 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9165582 0.81 L3MBTL1 (0.43) CYP2D6ALDH1A1TSHRMEN1KMT2A
SCHEMBL9165581 0.81 L3MBTL1 (0.43) CYP2D6ALDH1A1TSHRMEN1KMT2A
SCHEMBL8536881 0.81 L3MBTL1 (0.43) CYP2D6ALDH1A1TSHRMEN1KMT2A
SCHEMBL7116849 0.79 HTR2A (0.33) NPSR1CYP2D6TSHRTAAR1MEN1
SCHEMBL28418664 0.77 KDM4E (0.39) NPSR1CYP2D6ALDH1A1TSHRMEN1
SCHEMBL4085556 0.77 HTR2A (0.32) NPSR1CYP2D6TSHRTAAR1MEN1
SCHEMBL4080545 0.77 HTR2A (0.32) NPSR1CYP2D6TSHRTAAR1MEN1
SCHEMBL4080312 0.77 CES2 (0.33) NPSR1CYP2D6TSHRTAAR1MEN1
SCHEMBL2673956 0.77 SLC6A2 (0.45) CYP2D6ALDH1A1TSHRMEN1KMT2A
SCHEMBL27702104 0.75 LTA4H (0.41) NPSR1TSHRMEN1KMT2AGPR88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101208344-B (R) -N-methylnaltrexone, method for the synthesis thereof and pharmaceutical use thereof PROGENICS PHARM INC 2012-10-24 CN disclosed
CN-102721756-A Synthesis of (R)-N-methylnaltrexone PROGENICS PHARM INC 2012-10-10 CN disclosed
CN-101208344-A (R) -N-methylnaltrexone, method for the synthesis thereof and pharmaceutical use thereof PROGENICS PHARM INC (US) 2008-06-25 CN disclosed
EP-1913001-A2 (R)-N-METHYLNALTREXONE, PROCESSES FOR ITS SYNTHESIS AND ITS PHARMACEUTICAL USE PROGENICS PHARMACEUTICALS, INC. (US) 2008-04-23 EP disclosed
WO-2006127899-A2 (R)-N-METHYLNALTREXONE, PROCESSES FOR ITS SYNTHESIS AND ITS PHARMACEUTICAL USE PROGENICS PHARMACEUTICALS, INC. (US) 2006-11-30 WO disclosed